National Anti-Drug Office: Strengthening Crackdown on "Headed E-Cigarette

Jan.07.2025
National Anti-Drug Office: Strengthening Crackdown on "Headed E-Cigarette
State agencies issue new guidelines to crack down on illegal activities related to dangerous e-cigarettes, targeting youth health.

National Anti-Drug Office News: Recently, the National Anti-Drug Committee office, the Ministry of Public Security, and the State Tobacco Monopoly Administration jointly issued the "Opinions on Further Strengthening the Crackdown on Illegal Activities of 'Up Head E-cigarettes'" (hereinafter referred to as the "Opinions"), to deepen the crackdown on e-cigarettes related to drugs and banned substances. This is in line with the important instructions of General Secretary Xi Jinping on drug control work, and aims to provide strong support for strengthening departmental cooperation and systematically solving the problem of "Up Head E-cigarettes.


Currently, the misuse of new drugs and alternative substances such as "over-the-top e-cigarettes" containing mephedrone and synthetic cannabinoids among adolescents is escalating rapidly, seriously endangering the physical and mental health of the public, especially young people. In order to further strengthen the overall guidance for cracking down on "over-the-top e-cigarettes" and resolutely combat the phenomenon of e-cigarettes containing drugs and illegal substances, and to tightly prevent and effectively curb the misuse of "over-the-top e-cigarettes" among adolescents, the National Narcotics Control Committee Office, the Ministry of Public Security, and the State Tobacco Monopoly Administration jointly formulated this "Opinion.


The Opinion explicitly states the need to further strengthen the division of responsibilities among various levels of anti-drug offices, public security agencies, and tobacco monopoly departments in cracking down on "Shangtou e-cigarette" illegal activities, establishing communication mechanisms, enhancing departmental collaboration, and coordinating efforts to combat illegal activities. Firstly, it aims to crack down on illegal production and sales of e-cigarettes in accordance with the law. Secondly, it focuses on systematically addressing the illegal addition of drugs and alternative substances in e-liquids. Thirdly, it seeks to severely punish the illegal manufacture of new types of drugs and alternative substances such as mephitazine. Fourthly, it aims to promptly investigate and address the registration of smoking "Shangtou e-cigarettes." Finally, it aims to clean up and crack down on illegal activities related to "Shangtou e-cigarettes" on the internet.


The "Opinion" points out that public security organs and tobacco monopoly departments should establish a sound cooperation mechanism, strengthen information sharing, enhance situation reporting, case transfer, and information sharing, etc.; improve law enforcement cooperation, strengthen law enforcement linkage, focus on tracing and cracking down on illegal production and operation of e-cigarettes, illegal production of e-cigarettes related to drugs, and form a joint force; strengthen cooperation on monitoring drug substitute substances added to "overseas e-cigarettes", regularly summarize, analyze, evaluate, comprehensively grasp the information of illegal additive substances in "overseas e-cigarettes" and the situation of abuse.


The Opinion emphasizes that drug control offices, public security organs, and tobacco monopoly departments across the country should strengthen their responsibilities and establish a clear, coordinated, and efficient system for combating and managing, enhancing their capabilities to combat "upcoming e-cigarette" and new type of drug crimes; strengthen publicity and guidance, widely use various media to conduct propaganda on the harm of "upcoming e-cigarette" and drug control laws and regulations among young people; fully leverage the technical advantages of national drug laboratories and branches to provide technological support for combating illegal crimes related to "upcoming e-cigarette".


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
Product | BAT Expands VELO Peach Ice Medium to FamilyMart Stores Nationwide in Japan
British American Tobacco Japan (BAT Japan) expanded VELO Peach Ice Medium to FamilyMart stores nationwide in Japan from September 7, 2026. The oral tobacco product first launched on July 6 and had previously been sold through VELO's official online store, glo Store Ginza and tobacco retailers. It combines peach flavor with menthol cooling at a Medium strength level and is priced at JPY 360. Japanese tobacco retailers list 15 pouches per pack. The move adds the new SKU to an existing nationwide FamilyMart distribution network for VELO rather than marking the brand's first entry into the convenience-store chain.
Sep.15
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
Product | KUMI SCENIC 50K Offers Nicotine and 6-Methyl Nicotine Versions as 6-MN Products Appear in Multiple U.S. State Directories, With Louisiana Listing FDA Exemption
An October 2026 review of U.S. state vapor product directories found KUMI 6 SCENIC 50K listed in Louisiana and Nebraska. Louisiana classifies 20 related product entries as “FDA EXEMPTION.” The SCENIC platform is marketed in both conventional nicotine-salt and NoNic6 formulations, each advertised with 22mL e-liquid capacity and up to 50,000 puffs. U.S. wholesaler Midwest Goods listed both versions in August 2025 with a suggested retail price of $19.99 each. The NoNic6 version is associated with 6-methylnicotine and is also marketed by some distributors as “nicotine-free.”
product
Oct.27
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology Dropped From FTSE All-World as International Business Reaches 68.5% of Q2 Revenue
RLX Technology (NYSE: RLX) has been removed from the FTSE All-World Index, effective September 21. FTSE Russell records show RLX was already part of its global equity index universe by 2022, when its American depositary receipts were classified as China Large Cap securities. Trading volume rose to about 44.77 million shares on September 18, roughly 23 times the previous session's volume. RLX reported RMB1.0105 billion in second-quarter revenue, up 14.8% year over year, with international operations contributing 68.5%. The company also acquired a 51% stake in one of Western Europe's largest distributors of next-generation smoke-free and FMCG products in July.
Sep.22